Biography
Wendell Cole has completed his B.S. at the age of 20 years from Georgia State University and is a current MD2 student at Morehouse School of Medicine. He is a 2015 scholar of the American Academy of Orthopaedic Surgeons Nth dimensions educational solutions program. He has presented this poster at the National Medical Association 113th Annual Convention and Scientific Assembly in Detroit, MI
Abstract
Background: Osteoarthritis is the most common joint disorder in the world that will affect nearly half of all adults by age 85. The appropriate management in patients with mild to severe osteoarthritis still remains a challenging area where viscosupplemtation (SYNVISC) can play an important role.\r\nObjective: To analyze the efficacy of intra-articular injections of SYNVISC (Hylan G-F 20) for the treatment of Grade II-IV painful knee osteoarthritis using validated outcome scores (KOOS). \r\nDesign: This is a retrospective case series study including patients over a span of 6 years.\r\nParticipants: A convenience sample of 140 patients with Grade II-IV knee osteoarthritis participated in this study. Patients had an age range from 41-83 years of age with a mean age 60 years old. Patients were included if they completed a baseline KOOS survey and a 6-week follow-up KOOS survey after intra-articular injection of Hylan G-F 20. \r\nMain outcome: After Hylan G-F 20 injection, a significant increase (P<.05) in the KOOS survey categories of pain (17.4% increase), symptoms (14.7%), activities of daily life(15.1%), sports and recreation(11.6%) and knee related quality of life(20.2%) were seen. \r\nConclusion: Previous literature on viscosupplementation has shown a failure of efficacy based on a lack of statistically significant clinical improvement. The data from this study was statistically significant, and indicates that patients are satisfied and find it easier to perform daily activities with less knee pain after a viscosupplementation injection. Hylan G-F 20 injections provide good clinical benefits for the patient and are a safe treatment for knee osteoarthritis\r\n
Biography
Jamal Fitts has completed his BS from the University of Alabama at Birmingham. He is currently pursuing Medicine at Morehouse School of Medicine. He is an Nth Dimension Scholar of American Academy of Orthopedic Surgeons. He presented this poster at the National Medical Association 113th Annual Convention and Scientific Assembly
Abstract
Background: Peri-prosthetic joint infection (PJI) is the third leading reason for revision of total hip arthroplasty (THA). Two-stage exchange arthroplasty has become the “gold standard†for treatment of a chronically infected THA. This case demonstrates a classical presentation of a two-stage revision arthroplasty for the treatment of PJI. \r\n\r\nMethods & Patients: The patient presented to clinic with blood and purulence draining from a wound on his right hip. He previously had a THA and has had recurrent chronic infection. After evaluation of his blood sample and fluid aspirated from his hip, it was decided that it would be most appropriate to undergo a two-stage exchange arthroplasty. \r\n\r\nManagement & Outcome: The previous hip implant was removed. The antibiotic cement spacer was placed in without incident. \r\n\r\nDiscussion: After lab testing shows that the infection has been eradicated, the permanent prosthesis will be implanted. Two-stage revision is just one of the means of treatment for infection. The route of treatment depends on multiple factors that must be considered when managing the patient’s infection.\r\n